ARS Pharmaceuticals Inc
NASDAQ:SPRY
Wall Street
Price Targets
SPRY Price Targets Summary
ARS Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
SPRY
is 19.38 USD
with a low forecast of 19.19 USD and a high forecast of 19.95 USD.
SPRY Last Price Targets
ARS Pharmaceuticals Inc
The latest public price target was made on Mar 5, 2024 by
Roanna Ruiz
from
Leerink Partners
,
who expects
SPRY
stock to
rise by 90%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Roanna Ruiz
Leerink Partners
|
18
USD
Upside 90% |
1 month ago
Mar 5, 2024
|
Leerink Partners Upgrades ARS Pharmaceuticals Inc (SPRY) to Outperform
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SPRY's stock price target?
Price Target
19.38
USD
According to Wall Street analysts, the average 1-year price target for
SPRY
is 19.38 USD
with a low forecast of 19.19 USD and a high forecast of 19.95 USD.
What is ARS Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
1 685%
The
compound annual growth rate
of ARS Pharmaceuticals Inc's revenue for the next 3 years is
1 685%.
You don't have any saved screeners yet
